Insider Transactions in Q4 2024 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2024
|
Andrew J Murphy EVP Research |
SELL
Bona fide gift
|
Direct |
1,185
-2.45%
|
-
|
|
Nov 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-7.18%
|
$844,000
$844.61 P/Share
|
|
Nov 01
2024
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.7%
|
$381,000
$381.4 P/Share
|
|
Oct 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-7.18%
|
$1,054,000
$1054.06 P/Share
|
|
Oct 01
2024
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.7%
|
$381,000
$381.4 P/Share
|
|
Oct 01
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$104,900
$1049.73 P/Share
|